news

Researchers synthesise red blood cells with ability to deliver drugs

9
SHARES

Artificial red blood cells have been created by researchers which can be used as normal cells or to carry drugs around the body.

Red blood cells

A group of researchers has reported they have successfully developed synthetic red blood cells (RBCs) that have all the normal cells’ natural abilities but can also transport therapeutic drugs. 

 

Reserve your FREE place

 


Explore innovative, purpose-built AI solutions that elevate compliance and efficiency in quality and manufacturing operations.

17 September 2025 | 10:00 AM BST | FREE Webinar

In this webinar, find out how AI tools such as customised large language models (LLMs), orchestrated services, and human-in-the-loop design can streamline processes, enhance training, and improve efficiencies.

Don’t miss your chance to learn from industry experts – Register Now – It’s Free!

 

…the researchers found that the synthetic RBCs lasted for more than 48 hours, with no observable toxicity”

Conducted by researchers at the University of New Mexico, US and the South China University of Technology, the study revealed how the team made their cells by first coating donated human RBCs with a thin layer of silica. They then layered positively and negatively charged polymers over the silica-RBCs and etched away the silica, producing flexible replicas.

Finally, the team coated the surface of the replicas with natural RBC membranes. The artificial cells were similar in size, shape, charge and surface proteins to natural cells and they could squeeze through model capillaries without losing their shape.

In mice, the researchers found that the synthetic RBCs lasted for more than 48 hours, with no observable toxicity. The researchers loaded the artificial cells with either haemoglobin, an anticancer drug, a toxin sensor or magnetic nanoparticles to demonstrate that they could carry cargoes. The team also showed that the new RBCs could act as decoys for a bacterial toxin.

According to the researchers, future studies will explore the potential of the artificial cells in medical applications, such as cancer therapy and toxin biosensing.

The study was published in ACS Nano

Share via
Share via